Fundraising FoxMyrobalan Therapeutics
Boston, US · Founded 2023 · 1 known investors
Find your way into Myrobalan Therapeutics
Sign up to see every warm intro you have to Myrobalan Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Myrobalan Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Myrobalan Therapeutics is a pre-clinical biotech company developing small molecule therapies targeting microglia and oligodendrocytes to address neurodegeneration and demyelinating disorders. The company's precision medicines aim to promote remyelination and reduce neuroinflammation in conditions such as multiple sclerosis, Alzheimer's disease, and ALS.
Founders & leadership
Myrobalan Therapeutics was founded in 2023 by Jing Wang, PhD, Guoping Feng, PhD, Zhigang He, and Guoping Feng.
Investors · 1
How we know: a partner's Signal profile · the VCSheet dataset · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$24M disclosed across 1 round · 2024
▶$24MraisedJan 2024 · 12 investors · BiotechnologyRule 506(b)
- Guoping FengDirector
- Minmin YangDirector
- Zhigang HeDirector
- Jing Yu WangExecutive Officer, Director
- Shixiang YanDirector
- Offering amount
- $24M
- Amount sold
- $24M
- First sale
- Jan 2024
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Myrobalan Therapeutics do?
- Myrobalan Therapeutics is a pre-clinical biotech company developing small molecule therapies targeting microglia and oligodendrocytes to address neurodegeneration and demyelinating disorders. The company's precision medicines aim to promote remyelination and reduce neuroinflammation in conditions such as multiple sclerosis, Alzheimer's disease, and ALS.
- Who founded Myrobalan Therapeutics?
- Myrobalan Therapeutics was founded by Jing Wang, PhD, Guoping Feng, PhD, Zhigang He, Guoping Feng in 2023.
- Who are Myrobalan Therapeutics's investors?
- Myrobalan Therapeutics's investors include 3E Bioventures Capital.
- How much funding has Myrobalan Therapeutics raised?
- Myrobalan Therapeutics has disclosed $24M raised across 1 round.
- Where is Myrobalan Therapeutics headquartered?
- Myrobalan Therapeutics is headquartered in Boston, US.